Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 42

1.

Combination treatment for glioblastoma with temozolomide, DFMO and radiation.

Alexiou GA, Vartholomatos E, I Tsamis K, Peponi E, Markopoulos G, A Papathanasopoulou V, Tasiou I, Ragos V, Tsekeris P, Kyritsis AP, Galani V.

J BUON. 2019 Jan-Feb;24(1):397-404.

2.

Systemic therapy of metastatic renal cell carcinoma: Review of the current literature.

Zerdes I, Tolia M, Tsoukalas N, Mitsis M, Kardamakis D, Pistevou-Gombaki K, Tsekeris P, Kyrgias G.

Urologia. 2019 Feb;86(1):3-8. doi: 10.1177/0391560318802166. Epub 2018 Oct 1.

PMID:
30270773
3.

Development and validation of simple step protein precipitation UHPLC-MS/MS methods for quantitation of temozolomide in cancer patient plasma samples.

El Mubarak MA, Stylos EK, Chatziathanasiadou MV, Danika C, Alexiou GA, Tsekeris P, Renziehausen A, Crook T, Syed N, Sivolapenko GB, Tzakos AG.

J Pharm Biomed Anal. 2019 Jan 5;162:164-170. doi: 10.1016/j.jpba.2018.09.019. Epub 2018 Sep 8.

PMID:
30243056
4.

Addressing the post-irradiation hypothalamic-pituitary endocrine abnormalities of brain tumors in pediatric patients.

Velentza L, Tolia M, Christakou C, Nikolaou M, Zerdes I, Tsoukalas N, Hajiioannou J, Tsanadis K, Rigas G, Mitsis M, Theodorou K, Pistevou-Gombaki K, Tsekeris P, Kyrgias G.

J BUON. 2017 Sep-Oct;22(5):1240-1245.

5.

Preoperative Chemoradiation in Locally Advanced Rectal Cancer: Efficacy and Safety.

Peponi E, Skloupiotis V, Tsironis D, Tasiou I, Capizzello A, Tsironis C, Tsimoyiannis KE, Pitouli E, Tsimoyiannis E, Tsekeris P.

Gastroenterology Res. 2015 Dec;8(6):303-308. Epub 2015 Dec 31.

6.

Subtotal gastrectomy for diffused hemorrhagic gastritis induced by radiation, following liver resection for hilar cholangiocarcinoma. A case report.

Tatsis V, Peponi E, Papadopoulos G, Tsekeris P, Fatouros M, Glantzounis G.

Int J Surg Case Rep. 2016;18:30-2. doi: 10.1016/j.ijscr.2015.11.014. Epub 2015 Nov 21.

7.

3D conformal radiotherapy in primary nasopharyngeal cancer: effectiveness and prognostic factors.

Peponi E, Katinioti K, Tasiou I, Capizzello A, Tzallas G, Siontis G, Pitouli E, Tsekeris P.

J BUON. 2015 Mar-Apr;20(2):514-20.

8.

Combination treatment of TRAIL, DFMO and radiation for malignant glioma cells.

Alexiou GA, Tsamis KI, Vartholomatos E, Peponi E, Tzima E, Tasiou I, Lykoudis E, Tsekeris P, Kyritsis AP.

J Neurooncol. 2015 Jun;123(2):217-24. doi: 10.1007/s11060-015-1799-9. Epub 2015 May 3.

PMID:
25935110
9.

Prognostic factors in glioblastoma patients managed with radiotherapy combined with temozolomide.

Peponi E, Tourkantonis I, Tasiou I, Pavlidis N, Pentheroudakis G, Tsekeris P.

J BUON. 2014 Jul-Sep;19(3):718-23.

10.

Comparison of diffusion tensor, dynamic susceptibility contrast MRI and (99m)Tc-Tetrofosmin brain SPECT for the detection of recurrent high-grade glioma.

Alexiou GA, Zikou A, Tsiouris S, Goussia A, Kosta P, Papadopoulos A, Voulgaris S, Tsekeris P, Kyritsis AP, Fotopoulos AD, Argyropoulou MI.

Magn Reson Imaging. 2014 Sep;32(7):854-9. doi: 10.1016/j.mri.2014.04.013. Epub 2014 Apr 24.

PMID:
24848292
11.

Radiotherapy for prevention of heterotopic ossification of the elbow: a systematic review of the literature.

Ploumis A, Belbasis L, Ntzani E, Tsekeris P, Xenakis T.

J Shoulder Elbow Surg. 2013 Nov;22(11):1580-8. doi: 10.1016/j.jse.2013.07.045. Review.

PMID:
24138821
12.

Reirradiation for recurrent head and neck carcinoma.

Peponi E, Balta S, Tasiou I, Gogou P, Capizzello A, Pitouli E, Tsekeris P.

J BUON. 2012 Jul-Sep;17(3):465-70.

13.

Radiotherapy for Hodgkin's lymphoma: too hard to die?

Zygogianni AG, Kyrgias G, Psyrri A, Kantzou I, Koumarianou A, Tolia M, Tsekeris P, Tsirigotis P, Sarris G, Kouvaris J, Kouloulias V.

J BUON. 2012 Jan-Mar;17(1):116-23.

14.

Clinicopathologic study of E-cadherin/beta-catenin complex, and topoisomerase-II in a series of 71 liposarcoma cases.

Gogou P, Pakos E, Batistatou A, Panelos I, Briasoulis E, Stefanou D, Apostolikas N, Tsekeris P.

World J Surg Oncol. 2012 Feb 2;10:28. doi: 10.1186/1477-7819-10-28.

15.

Prognostic significance of MRP5 immunohistochemical expression in glioblastoma.

Alexiou GA, Goussia A, Voulgaris S, Fotopoulos AD, Fotakopoulos G, Ntoulia A, Zikou A, Tsekeris P, Argyropoulou MI, Kyritsis AP.

Cancer Chemother Pharmacol. 2012 May;69(5):1387-91. doi: 10.1007/s00280-012-1832-z. Epub 2012 Jan 26.

PMID:
22278731
16.

Diffusion tensor and dynamic susceptibility contrast MRI in glioblastoma.

Zikou AK, Alexiou GA, Kosta P, Goussia A, Astrakas L, Tsekeris P, Voulgaris S, Malamou-Mitsi V, Kyritsis AP, Argyropoulou MI.

Clin Neurol Neurosurg. 2012 Jul;114(6):607-12. doi: 10.1016/j.clineuro.2011.12.022. Epub 2012 Jan 21.

PMID:
22266399
17.

Myocardial perfusion imaging with (99 m)Tc-tetrofosmin SPECT in breast cancer patients that received postoperative radiotherapy: a case-control study.

Sioka C, Exarchopoulos T, Tasiou I, Tzima E, Fotou N, Capizzello A, Ragos V, Tsekeris P, Fotopoulos A.

Radiat Oncol. 2011 Nov 8;6:151. doi: 10.1186/1748-717X-6-151.

18.

Pure small cell carcinoma of the prostate: a case report and literature review.

Capizzello A, Peponi E, Simou N, Ntaskagiannis D, Tasiou I, Kamina S, Tsekeris P.

Case Rep Oncol. 2011 Feb 16;4(1):88-95. doi: 10.1159/000324717.

19.
20.

Randomized phase II exploratory study of prophylactic amifostine in cancer patients who receive radical radiotherapy to the pelvis.

Katsanos KH, Briasoulis E, Tsekeris P, Batistatou A, Bai M, Tolis C, Capizzello A, Panelos I, Karavasilis V, Christodoulou D, Tsianos EV.

J Exp Clin Cancer Res. 2010 Jun 10;29:68. doi: 10.1186/1756-9966-29-68.

Supplemental Content

Loading ...
Support Center